Fig. 4.
![Fig. 4. RT-PCR analysis of the expression of CD30, CD30L, CD40, CD40L, Fas, FasL, and control β-actin mRNA in GLs from 6 LDGL patients. / Lane 1 indicates molecular weight marker (100 base pairs [bp] DNA ladder); lane 2: control peripheral blood mononuclear cells stimulated for 12 hours with PHA (5 μg/mL) (positive control) for CD30, CD30L, CD40L, and FasL; positive control for CD40 was represented by purified B lymphocytes; lane 3: the negative control (sample without cDNA), lanes 4 to 6: 3 CD3+ LDGL cases (cases 3, 8, and 13 in Table 1), lane 7 to 9: 3 CD3− LDGL (cases 15, 17, and 20 in Table 1).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/96/2/10.1182_blood.v96.2.647/5/bloo01418004w.jpeg?Expires=1735564863&Signature=Dxu-khYAxa9r5CFeVb6koQXjACXv0Q4aNF3FgZ0PF1cvrCNjbHP0QKyEioKAUik0CKicQLMMDfKbxqeMpNHfo9xahcffEhybsKCHTfukhGuWd6qUI7JkMpc~BmKdRZQt0LY0zjjzFYuIx-RHAuvVfxAE7kyJWRPf40W51Tl2L0LFvBz-dBYKfDLkf1DAPvg0JQW4H60hjimdpBlTqRsPNHsw0MDw901WkBYw9-f2AH-vx7MQM3Aq9Fn2BGKo~1e97jfq9vsB-Sy14csoWHDq5A4cjR6enDgGsZwvbhYi2mhxd1fiDfbZhSwHQaNFV1TZZrfFw81mlGgiYBig8lBoMg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
RT-PCR analysis of the expression of CD30, CD30L, CD40, CD40L, Fas, FasL, and control β-actin mRNA in GLs from 6 LDGL patients.
Lane 1 indicates molecular weight marker (100 base pairs [bp] DNA ladder); lane 2: control peripheral blood mononuclear cells stimulated for 12 hours with PHA (5 μg/mL) (positive control) for CD30, CD30L, CD40L, and FasL; positive control for CD40 was represented by purified B lymphocytes; lane 3: the negative control (sample without cDNA), lanes 4 to 6: 3 CD3+ LDGL cases (cases 3, 8, and 13 in Table 1), lane 7 to 9: 3 CD3− LDGL (cases 15, 17, and 20 in Table 1).
